| P2093 | author name string | Roodman GD | |
| P2860 | cites work | Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine | Q24298662 |
| | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 |
| | Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 |
| | Expression of two human skeletal calcitonin receptor isoforms cloned from a giant cell tumor of bone. The first intracellular domain modulates ligand binding and signal transduction | Q24320379 |
| | Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6 | Q24563585 |
| | Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 |
| | Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification | Q28307228 |
| | Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin | Q28511417 |
| | Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice | Q29547898 |
| | Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures | Q33636797 |
| | Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption | Q34138159 |
| | Interleukin-11: a new cytokine critical for osteoclast development | Q34138407 |
| | Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation | Q34193938 |
| | Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo | Q34224284 |
| | Osteoclastic bone resorption by a polarized vacuolar proton pump | Q34441726 |
| | Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro | Q34459310 |
| | Bidirectional regulation of osteoclast function by nitric oxide synthase isoforms | Q34520984 |
| | Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures | Q34540942 |
| | Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones | Q34610078 |
| | Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src-/- mutant mice | Q35194925 |
| | Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells | Q35412006 |
| | Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone | Q35595884 |
| | Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice | Q35607627 |
| | Transforming growth factor-beta 1 as a signal for induction of cell death by apoptosis | Q35975984 |
| | Identification and characterization of osteoclast-like cells and their progenitors in cultures of feline marrow mononuclear cells | Q36210851 |
| | Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells | Q36230062 |
| | Substrate recognition by osteoclast precursors induces C-src/microtubule association. | Q36274033 |
| | Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts. | Q36301037 |
| | In vitro formation of osteoclasts from long-term cultures of bone marrow mononuclear phagocytes | Q36347206 |
| | Osteoblasts mediate interleukin 1 stimulation of bone resorption by rat osteoclasts | Q36352137 |
| | Osteoblastic cells mediate osteoclastic responsiveness to parathyroid hormone | Q36458074 |
| | Characterization of the osteoclast vacuolar H+-ATPase B-subunit | Q36690409 |
| | New resorption assay with mouse osteoclast-like multinucleated cells formed in vitro | Q36697460 |
| | Osteoporosis induced in mice by overproduction of interleukin 4. | Q36716814 |
| | Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor. | Q37377903 |
| | Immortalization of osteoclast precursors by targeting Bcl -XL and Simian virus 40 large T antigen to the osteoclast lineage in transgenic mice | Q37387048 |
| | Avian osteoclasts as estrogen target cells | Q37557847 |
| | 1,25-Dihydroxyvitamin D3 causes formation of multinucleated cells with several osteoclast characteristics in cultures of primate marrow | Q37557858 |
| | Homologous regulation of the calcitonin receptor in mouse osteoclast-like cells and human breast cancer T47D cells | Q38294720 |
| | Calcitonin receptor isoforms in mouse and rat osteoclasts | Q38300547 |
| | c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption. | Q38352423 |
| | Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone | Q39116021 |
| | Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin | Q39116155 |
| | Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice | Q40512172 |
| | Generation of mouse osteoclastogenic cell lines immortalized with SV40 large T antigen | Q41026072 |
| | Inhibitory and stimulatory effects of prostaglandins on osteoclast differentiation | Q41141652 |
| | Role of osteoblasts in hormonal control of bone resorption—A hypothesis | Q41551873 |
| | Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts | Q41773356 |
| | Interleukin-6 is produced by bone and modulated by parathyroid hormone | Q43600464 |
| | Carbonic anhydrase and bone remodeling: sulfonamide inhibition of bone resorption in organ culture | Q44036900 |
| | Formation of multinucleated cells that respond to osteotropic hormones in long term human bone marrow cultures | Q44145438 |
| | Humoral and ionic regulation of osteoclast acidity | Q44647666 |
| | Parathyroid hormone-related protein and interleukin-1 alpha synergistically stimulate bone resorption in vitro and increase the serum calcium concentration in mice in vivo | Q44903982 |
| | Production of lymphotoxin, a bone-resorbing cytokine, by cultured human myeloma cells | Q45211461 |
| | Inhibiting and stimulating effects of TGF-beta 1 on osteoclastic bone resorption in fetal mouse bone organ cultures | Q46192845 |
| | Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. | Q51005281 |
| | Osteoclastogenesis inhibitory factor (OCIF) directly inhibits bone-resorbing activity of isolated mature osteoclasts. | Q52532345 |
| | Interleukin-4 inhibits spontaneous and parathyroid hormone-related protein-stimulated osteoclast formation in mice. | Q53955397 |
| | Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. | Q54137269 |
| | Preparation and characterization of a mouse osteoclast-like multinucleated cell population. | Q54259715 |
| | 1,25(OH)2D3 induces differentiation of osteoclast-like cells from human bone marrow cultures. | Q54296184 |
| | Formation of osteoclasts and osteoblast-like cells in long-term human bone marrow cultures. | Q54300589 |
| | Osteoblastic cells are involved in osteoclast formation. | Q54374668 |
| | c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling | Q58326943 |
| | The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene | Q59092154 |
| | Isolated osteoclasts in primary culture: first observations on structure and survival in culture media. | Q64937800 |
| | Expression of human transforming growth factor alpha by Chinese hamster ovarian tumors in nude mice causes hypercalcemia and increased osteoclastic bone resorption | Q68231184 |
| | Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures | Q68274092 |
| | Identification of committed mononuclear precursors for osteoclast-like cells formed in long term human marrow cultures | Q68504882 |
| | Interleukin-4 as a potent inhibitor of bone resorption | Q68610452 |
| | Prostaglandin E2 inhibits formation of osteoclastlike cells in long-term human marrow cultures but is not a mediator of the inhibitory effects of transforming growth factor beta | Q68911249 |
| | A synthetic analogue of vitamin D3, 22-oxa-1 alpha,25-dihydroxyvitamin D3, is a potent modulator of in vivo immunoregulating activity without inducing hypercalcemia in mice | Q69340235 |
| | Two squamous cell carcinomas not associated with humoral hypercalcemia produce a potent bone resorption-stimulating factor which is interleukin-1 alpha | Q69353084 |
| | Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis | Q69354510 |
| | The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells | Q69541163 |
| | Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro | Q69738552 |
| | Isolated osteoclasts and their presumed progenitor cells, the monocyte, in culture | Q70545151 |
| | Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo | Q71207806 |
| | Ultrastructural immunocytochemical localization of carbonic anhydrase in normal and calcitonin-treated chick osteoclasts | Q71632492 |
| | Comparative study of inhibitory effects by murine interferon ? and a new bisphosphonate (alendronate) in hypercalcemic, nude mice bearing human tumor (LJC-1-JCK) | Q71649346 |
| | Stimulation of bone resorption in vitro by a non-prostanoid factor released by human monocytes in culture | Q71731720 |
| | Isolation and Characterization of Highly Enriched, Prefusion Mouse Osteoclastic Cells | Q71975600 |
| | Osteoclast synthesis and secretion and activation of latent transforming growth factor beta | Q72058811 |
| | Use of an in vivo model to determine the effects of interleukin-1 on cells at different stages in the osteoclast lineage | Q72248104 |
| | Interleukin-4 modulates osteoclast differentiation and inhibits the formation of resorption pits in mouse osteoclast cultures | Q72607646 |
| | Macrophage colony-stimulating factor release and receptor expression in bone cells | Q72763632 |
| | Ovariectomy decreases the mRNA levels of transforming growth factor-beta 1 and increases the mRNA levels of osteocalcin in rat bone in vivo | Q72883377 |
| | Osteoprotegerin and its cognate ligand: a new paradigm of osteoclastogenesis | Q77180502 |
| P433 | issue | 8 | |
| P921 | main subject | cell biology | Q7141 |
| P304 | page(s) | 1229-1241 | |
| P577 | publication date | 1999-08-01 | |
| P1433 | published in | Experimental Hematology | Q5421109 |
| P1476 | title | Cell biology of the osteoclast | |
| P478 | volume | 27 | |